Yet, there were no differences between CD and non‐IBD IgA1 (Fig 5F), whereas de‐glycosylated IgA2 from CD patients were more neutralizing than their non‐IBD counterparts (Fig 5G). The gene discussed is IGHA1; the disease is Cowden disease.